Incidence and prognostic factors for airflow obstruction in sarcoidosis
Conclusion: AO is frequent (36%) in sarcoid patients requiring treatment for disease deterioration. Several prognostic factors were disclosed, however randomised study is necessary to evaluate AO nature in sarcoid patients.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Bednarek, M., Goljan-Geremek, A., Puscinska, E., Nowinski, A., Korzybski, D., Sliwinski, P. Tags: 1.5 Diffuse Parenchymal Lung Disease Source Type: research
More News: Asthma | Chronic Obstructive Pulmonary | Laboratory Medicine | Methotrexate | Respiratory Medicine | Sarcoidosis | Spirometry | Study